Stay updated on KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial
Sign up to get notified when there's something new on the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page.

Latest updates to the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice about a lapse in government funding and current operations status was added, with links to cc.nih.gov and opm.gov, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check10 days agoChange DetectedAdded a glossary toggle and updated labeling for Study Record updates and FEAR Act wording, with the revision set to v3.4.0. The previous labels—'Last Update Submitted that met QC Criteria' (case change) and 'No FEAR Act data'—as well as the prior revision v3.3.4 were replaced.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 with no substantive content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a Locations section with Western Australia as a new site. Removed the Western Australia Locations header and the HHS Vulnerability Disclosure footer link; the page revision updated to v3.3.3.SummaryDifference0.2%

- Check74 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed on the page.SummaryDifference0.1%

- Check81 days agoChange DetectedRemoved the government funding/operating status notice from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page.